Long‐Bin Jeng

7.0k citations
189 papers · 5.6k · 3 hit papers · h-index 39

Impact in

  • Hepatology top 0.5%
    • Hepatocellular Carcinoma Treatment and Prognosis
  • Surgery top 2%
    • Cholangiocarcinoma and Gallbladder Cancer Studies
    • Organ Transplantation Techniques and Outcomes

Papers in

    • Liver Disease and Transplantation 28
    • Hepatocellular Carcinoma Treatment and Prognosis 25
    • Organ Transplantation Techniques and Outcomes 37
    • Transplantation: Methods and Outcomes 10
    • Cholangiocarcinoma and Gallbladder Cancer Studies 9

Long‐Bin Jeng

186 papers receiving 5.4k citations

Long‐Bin Jeng's Hit Papers

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma 2024 · 229 citations
2290+4+8Years since publication200400600

Peers

Long‐Bin Jeng
Comparison fields: 5 of 131
  • Hepatology 1.7k
  • Surgery 1.5k
  • Oncology 881
  • Emergency Medicine 295
  • Cancer Research 477
Replace Christian H. Herfarth with:
Christian H. Herfarth Germany
Georg Oberhuber Austria
Henrik Petrowsky Switzerland
Sarangarajan Ranganathan United States
Matthias Glanemann Germany
Onno T. Terpstra Netherlands
Umberto Baccarani Italy
Laura Rubbia‐Brandt Switzerland
Max Georg Bachem Germany
Christine Silvain France
Long‐Bin Jeng relative to Christian H. Herfarth Germany Christian H. Herfarth's profile →
Citations per field
00.5×5×10×14.3×
Christian H. Herfarth · 1×
Citations per year

Countries citing papers authored by Long‐Bin Jeng

Since Specialization
Citations

This map shows the geographic impact of Long‐Bin Jeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Long‐Bin Jeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Long‐Bin Jeng more than expected).

Fields of papers citing papers by Long‐Bin Jeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Long‐Bin Jeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Long‐Bin Jeng. The network helps show where Long‐Bin Jeng may publish in the future.

Co-authors

The 25 scholars most cited alongside Long‐Bin Jeng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Long‐Bin Jeng Line = papers co-authored together Long‐Bin Jeng links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 189 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
Hit paper breakdown →
2013656
2
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
Hit paper breakdown →
2023313
3
Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
Hit paper breakdown →
2024229
4 1997138
5 2009128
6 2011124
7 2011118
8 2011118
9 199699
10 200694
11 199791
12 201185
13 201184
14 200372
15 198971
16 199970
17 199867
18 201362
19 200559
20 201758

About Long‐Bin Jeng

Long‐Bin Jeng is a scholar working on Hepatology, Surgery, Cancer Research, Pulmonary and Respiratory Medicine and Epidemiology, having authored 189 papers that have together received 5.6k indexed citations. Recurring topics across this work include Organ Transplantation Techniques and Outcomes (37 papers), Liver Disease and Transplantation (28 papers), Hepatocellular Carcinoma Treatment and Prognosis (25 papers), Liver Disease Diagnosis and Treatment (13 papers), Hepatitis B Virus Studies (11 papers), Transplantation: Methods and Outcomes (10 papers), Gallbladder and Bile Duct Disorders (9 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers). The work is most often cited by research in Hepatology (1.7k citations), Surgery (1.5k citations), Oncology (881 citations), Emergency Medicine (295 citations) and Cancer Research (477 citations). Long‐Bin Jeng has collaborated with scholars based in Taiwan, United States and Saudi Arabia. Frequent co-authors include Horng-Ren Yang, Miin‐Fu Chen, Miin-Fu Chen, Tzu‐Chieh Chao, Ping‐Kuei Chung, Wei‐Chen Lee, Ray‐Jade Chen, Chia‐Siu Wang, Chiao‐Fang Teng and Chia‐Hung Kao. Their work appears in journals such as Clinica Chimica Acta, Cancer Letters, World Journal of Surgery, PLoS ONE and Liver Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact